Avego Bioscience Capital, L.P.
Avego Bioscience Capital, L.P. is a private equity fund based in Alpharetta, Georgia. According to its most recent Form D, filed Mar 7, 2025, it has sold $68,741,447 of interests to 18 investors since its first sale in Jan 2021. The filing does not set a minimum investment. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Avego Management, LLC; Velan Capital Invesment Management LP; Avego Bioscience Capital GP, LLC.
- Total raised
- $68,741,447Cumulative sales reported on Form D
- Investors
- 18
- First sale
- Jan 12, 2021
- Minimum investment
- None set
- Who can invest
- Qualified purchasersSection 3(c)(7): generally $5M+ in investments
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- Avego Management, LLC; Velan Capital Invesment Management LP; Avego Bioscience Capital GP, LLC
- Latest Form D
- Mar 7, 2025
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about Avego Bioscience Capital, L.P.
What is the minimum investment for Avego Bioscience Capital, L.P.?
Avego Bioscience Capital, L.P.'s latest Form D, filed Mar 7, 2025, does not set a minimum investment. Managers can still require one in the offering documents.
Who can invest in Avego Bioscience Capital, L.P.?
Avego Bioscience Capital, L.P. is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(b), which does not allow general advertising.
How much has Avego Bioscience Capital, L.P. raised?
Avego Bioscience Capital, L.P. reports $68,741,447 sold from 18 investors on its Form D filed Mar 7, 2025. This is cumulative sales since the offering began, not current assets or performance.
Where is Avego Bioscience Capital, L.P. based?
Avego Bioscience Capital, L.P. is based in Alpharetta, Georgia and is managed by Avego Management, LLC.
When did Avego Bioscience Capital, L.P. launch?
Avego Bioscience Capital, L.P. reports its first sale in Jan 2021.
Size compared with every private equity fund
Raised more than 81% of the 124 private equity funds based in Georgia, and more than 68% of all 9,142 that report sales.